Sex Differences in Risk for Iatrogenic Thyrotoxicosis Among Older Adults: An Analysis from Real-World Clinical Data

被引:0
|
作者
Adams, Roy [1 ,2 ]
Mammen, Jennifer Sophie [3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA
[2] Johns Hopkins Whiting Sch Engn, Dept Comp Sci, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, 5501 Hopkins Bayview Circle Asthma & Allergy Ctr 2, Baltimore, MD 21224 USA
关键词
hypothyroidism; levothyroxine; iatrogenic thyrotoxicosis; health disparities; LEAN BODY-MASS; THYROID-HORMONE; LEVOTHYROXINE DOSAGE; ATRIAL-FIBRILLATION; THERAPY; CANCER;
D O I
10.1089/thy.2024.0604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Overtreatment with thyroid hormone is common and is associated with multiple adverse health outcomes, especially in older adults. Higher overtreatment rates have been reported among women. Understanding this sex difference could lead to better clinical utilization of therapy in at-risk populations. Methods: We performed a retrospective cohort study to examine the relationship between iatrogenic thyrotoxicosis and patient sex, adjusting for demographics, comorbidities, body composition, and thyroid hormone dosing using electronic health records for adults age 50 and older in a large community health system in the United States. Results: A total of 20,724 patients met all inclusion criteria, of whom 77% were female and 23% non-White. Women were more likely to have a low thyrotropin (TSH) compared to men (36.7% vs. 23.9%; unadjusted hazard ratio [HR] = 1.67 [95% confidence interval {CI} 1.56-1.79]). Many covariates varied by sex, including rates of several comorbidities, and there was a small but statistically significant difference in the median daily levothyroxine dose per actual body mass: 1.1 mu g/kg in male patients compared with 1.2 mu g/kg in female patients (p < 0.001). Adjusting for covariates other than dose did not significantly change the sex-related risk of iatrogenic thyrotoxicosis. In fully adjusted Cox models including dose per actual body mass, the female versus male HR = 1.50 [CI 1.34-1.69] was also not different from models which did not account for dose (p = 0.422). However, the association between female sex and thyrotoxicosis risk was partially mediated when adjusting for dose per ideal body mass (HR = 1.30 [CI: 1.16-1.46]; p < 0.001) and was fully mediated by dose calculated using lean body mass (HR = 1.06 [CI: 0.95-1.19]; p < 0.001). That is, women had higher risk of iatrogenic thyrotoxicosis compared to men receiving similar actual body mass doses, whereas women and men receiving comparable lean body mass doses had comparable risk. Conclusions: Mediation analysis demonstrates that the increased risk of iatrogenic thyrotoxicosis in older women may be attributable to differences in body composition between men and women. The use of ideal or lean body weight-based dose calculators in place of actual body weight dosing could reduce this potential source of iatrogenic thyrotoxicosis risk in older women.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] FRACTURES IN ADULTS AGE EIGHTY AND OLDER IN COLOMBIA: A REAL-WORLD DATA ANALYSIS
    Rosselli, D.
    VALUE IN HEALTH, 2024, 27 (06) : S390 - S390
  • [2] The real-world safety of sacubitril / valsartan among older adults (≥75): A pharmacovigilance study from the FDA data
    Lerman, Tsahi T.
    Greenberg, Noam
    Fishman, Boris
    Goldman, Adam
    Talmor-Barkan, Yeela
    Bauer, Menachem
    Goldberg, Idan
    Goldberg, Elad
    Kornowski, Ran
    Krause, Ilan
    Levi, Amos
    Cohen, Eytan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 397
  • [3] Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications
    Keita Tokumitsu
    Norio Sugawara
    Naoto Adachi
    Yukihisa Kubota
    Yoichiro Watanabe
    Kazuhira Miki
    Takaharu Azekawa
    Koji Edagawa
    Eiichi Katsumoto
    Seiji Hongo
    Eiichiro Goto
    Hitoshi Ueda
    Masaki Kato
    Reiji Yoshimura
    Atsuo Nakagawa
    Toshiaki Kikuchi
    Takashi Tsuboi
    Koichiro Watanabe
    Norio Yasui-Furukori
    Annals of General Psychiatry, 22
  • [4] Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications
    Tokumitsu, Keita
    Sugawara, Norio
    Adachi, Naoto
    Kubota, Yukihisa
    Watanabe, Yoichiro
    Miki, Kazuhira
    Azekawa, Takaharu
    Edagawa, Koji
    Katsumoto, Eiichi
    Hongo, Seiji
    Goto, Eiichiro
    Ueda, Hitoshi
    Kato, Masaki
    Yoshimura, Reiji
    Nakagawa, Atsuo
    Kikuchi, Toshiaki
    Tsuboi, Takashi
    Watanabe, Koichiro
    Yasui-Furukori, Norio
    ANNALS OF GENERAL PSYCHIATRY, 2023, 22 (01)
  • [5] Understanding sex differences in cardiovascular medicine: a plea for combining clinical trials with real-world data
    Boersma, Eric
    NETHERLANDS HEART JOURNAL, 2024, 32 (09) : 315 - 316
  • [6] From clinical trials to real-world practice: Immune checkpoint inhibitors in older adults
    Loh, Kah Poh
    Wong, Melisa L.
    Maggiore, Ronald
    JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (03) : 385 - +
  • [7] The effects of real-world knowledge on text processing among older adults
    Miller, LMS
    AGING NEUROPSYCHOLOGY AND COGNITION, 2001, 8 (02) : 137 - 148
  • [8] Myopia progression in young adults: insights from real-world clinical data
    Manoharan, Manoj K.
    Tivari, Uday Prasad
    Reddy, Jagadesh C.
    Verkicharla, Pavan K.
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2025,
  • [9] The real-world safety of ticagrelor among older adults (above 75 years): a pharmacovigilance study from the FDA data
    Lerman, T.
    Yacoby, I.
    Fishman, B.
    Goldman, A.
    Talmor-Barkan, Y.
    Itelman, E.
    Orvin, K.
    Eisen, A.
    Kornowski, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [10] The real-world safety of ticagrelor among older adults (above 75 years): a pharmacovigilance study from the FDA data
    Lerman, T.
    Yacoby, I
    Fishman, B.
    Goldman, A.
    Talmor-Barkan, Y.
    Itelman, E.
    Orvin, K.
    Eisen, A.
    Kornowski, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2024, 45